SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808805-24-000052
Filing Date
2024-06-17
Accepted
2024-06-17 18:09:14
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718662147.html 4  
1 FORM 4 wk-form4_1718662147.xml 4 4132
  Complete submission text file 0001808805-24-000052.txt   5662
Mailing Address 1000 SECOND AVENUE SUITE 3700 SEATTLE WA 98104
Business Address
McIlwain Matthew S (Reporting) CIK: 0001381752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 241049607

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)